Pharmacologic treatment of psychosis and pervasive developmental disorders in adolescents

Adolescent Psychiatry

Volumn 24, Issue , 1999, Pages 271-293

  Bernal Schnatter, Ileana ^a   Hendren, Robert L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033264597     PISSN: 00652008     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (59)

1. American Psychiatric Association (1994), Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: APA.
2. Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R. & Young, J. G. (1987), Whole blood serotonin in autistic and normal subjects. J. Child Psychol. Psychiat., 28:885-900.
3. Armenteros, J., Whitaker, A., Welikson, M., Stedge, D. & German, J. (1997), Risperdone in adolescents with schizophrenia: An open pilot study. J. Amer. Acad. Child Adolesc. Psychiat., 36:694-700
4. Bartak, L., Rutter, M. & Cox, A. (1995), A comparative study of infantile autism and specific developmental receptive language disorder, I: The children. Br. J. Psychiat., 126:127-145.
5. Biederman, J., Klein, R. G., Pine, D. S. & Klein D. F. (1998), Resolved: Mania is mistaken for ADHD in prepubertal children. Amer. J. Child Adolesc. Psychiat., 37:1091-1099.
6. _ Spencer, T. & Wilens, T. (1997), Psychopharmacology. In: Textbook of Child & Adolescent Psychiatry, ed. J. M. Wiener. Washington, DC: American Psychiatric Press, 49:779-812.
7. Bloomquist, H. K., Bohman, M., Edvinsson, S. O., Gillberg, C., Gustavson, K. H., Holmgren, G. & Wahlstrom, J. (1985), Frequency of fragile X syndrome in infantile autism. Clin. Genetics, 27:113-117.
8. Bregman, J., Volkmar, F. & Cohen, D. (1991), Fluoxetine in the treatment of autistic disorder. Scientific Proceedings of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry, 7:52.
9. Buitelar, J. K., Willemsen-Swinkels, S. & Van Engeland, H. (1998), Naltrexone in children with autism [Letter]. J. Amer. Acad. Child Adolesc. Psychiat., 37:800-801.
10. Burd, L., & Kerbeshian, I. (1987), A North Dakota prevalence study of schizophrenia presenting in childhood. J. Amer. Acad. Child Adolesc. Psychiat., 26:347-350.
11. Campbell, M., Anderson, L. T., Meier, M., Cohen, I. L., Small, A. M., Samit, C. & Sachar, E. J. (1978), A comparison of haloperidol and behavior therapy and their interaction in autistic children. J. Amer. Acad. Adolesc. Child Psychiat., 17:640-655.
12. _ & Shay, J. (1995), Pervasive developmental disorders. In: Comprehensive Textbook of Psychiatry, ed. H. I. Kaplan & B. J. Sadock. Baltimore, MD: Williams & Wilkins, 37:2277-2294.
13. Cantwell, D. P., Baker, L., Rutter, M. & Mawhood, L. (1989), Infantile autism and developmental dysphasia: A comparative follow-up into middle childhood. J. Autism Dev. Disord., 19:19-31.
14. Caplan, R., Guthrie, D., Gish, B., Tanguay, P. & David-Lando, G. (1989), The Kiddie Formal Thought Disorder Scale: Clinical assessment, reliability, and validity. J. Amer. Acad. Child Adolesc. Psychiat., 28:408-416.
15. Chess, S. (1977), Follow-up report on autism in congenital rubella. J. Autism Dev. Disord." 7:69-81.
16. Cohen, I. L., Campbell, M., Posner, D., Triebel, D., Small, A. M. & Anderson, L. T. (1980), A study of haloperidol in young autistic children: A within-subjects design using objective rating scales. Psychopharmacol. Bull., 16:63-65.
17. Commings, D. E. & Commings, B. G. (1991), Clinical and genetic relationship between autism-pervasive developmental disorder and Tourette's syndrome: A study of 19 cases.
18. Conner, D. F., Ozbaynak, K. R., Benjamin, S., Ma, Y. & Fletcher, K. E. (1997), A pilot study of nadolol for overt aggression in developmentally delayed individuals. J. Amer. Acad. Child Adolesc. Psychiat., 36:826-834.
19. Cook, E. H. Jr., Rowlette, R., Jaselski, C. & Leventhal, B. L. (1992), Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J. Amer. Acad. Child Adolesc. Psychiat., 31:739-745.
20. _ Leventhal, B. L. & Freedman, D. X. (1998), Free serotonin in plasma: Autistic children and their first degree relatives. Biol. Psychiat., 24:488-491.
21. Evans, J. & Acton, W. P. (1972), A psychiatric service for the disturbed adolescent. Br. J. Psychiat., 120:429-432.
22. Findling, R. L., Maxwell, K. & Wiznitzer, M. (1997), An open clinical trial of risperidone monotherapy in young children with autistic disorders. Psychopharmacol. Bull., 33:155-159.
23. Frankhauser, M. P., Karumanchi, V. C., German, M. L., Yates, A. & Karumanchi, S. D. (1992), A double-blind placebo-controlled study of the efficacy of transdermal clonidine in autism. J. Clin. Psychiat., 53:77-82.
24. Ghazinddin, M. & Tsai, L. Y. (1991), Depression in autistic disorder. Br. J. Psychiat., 159:721-723.
25. Gillberg, C. (1995), Clinical Child Neuropsychiatry. Cambridge, England: Cambridge University Press.
26. _ & Srendsen, P. (1987), CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br. J. Psychiat., 151:89-94.
27. _ Terenius, L., Hagberg, B., Witt-Engerstrom, I. & Eriksson, I. (1990), CSF beta-endorphins in childhood neuropsychiatric disorders. Brain Dev., 12:88-92.
28. Gordon, C., State, R. & Nelson, J. (1993), A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch. Gen. Psychiat., 50:441-447.
29. Green, W. H., Campbell, M., Hardesty, A. S., Grega, D. M., Padron-Gayol, M., Shell, J. & Erlenmeyer-Kimling, L. (1984), A comparison of schizophrenic and autistic children. J. Amer. Acad. Child Adolesc. Psychiat., 23:399-409.
30. Jaselski, C. A., Cook, E. H., Jr., Fletcher, K. E. & Leventhal, B. L. (1992), Clonidine treatment of hyperactive and impulsive children with autistic disorder. J. Clin. Psychopharmacol., 12:322-327.
31. Kerbeshian, J. & Burd, L. (1996), Case study: Comorbidity among Tourette's syndrome autistic disorder, and bipolar disorder. J. Amer. Acad. Child Adolesc. Psychiat., 35:681-685.
32. Kobayashi, R., Murata, T. & Yoshinaga, K. (1992), A follow-up study of 201 children with autism in Kyushu and Yamaguchi areas, Japan. J. Autism Dev. Disord., 22:395-411.
33. Kolvin, I. (1971), Studies in childhood psychoses. I: Diagnostic criteria and classification. Br. J. Psychiat., 118:381-384.
34. Krishnamoorthy, J. & King, B. H. (1998), Open-label olanzapine treatment in five preadolescent children. J. Child Adoles. Psychopharmacol., 8:107-113.
35. Kumra, S., Frazier, J. A., Jacobsen, L. K., McKenna, K., Gordon, C. T., Hamburger, S., Smith, A. K., Albus, K. E., Alaghband-Rad, J., Lenane, M. & Rapoport J. L. (1996), Childhood-onset schizophrenia: A double-blind clozapine haloperidol comparison. Arch. Gen. Psychiat., 53:1090-1097.
36. _ Herian, D., Jacobsen, L., Brigeglin, C. & Groethe, D. (1997), Case study: Risperidone-induced hepatotoxicity in pediatric patients. J. Amer. Acad. Child Adolesc. Psychiat., 36:701-705.
37. _ Jacobsen, L. K., Lenane, M., Karp, B. I., Frazier, J. A., Smith, A. K., Bedwell, J., Lee, P., Malanga, C. J., Hamburger, S. & Rapoport, J. L. (1998), Childhood-onset schizophrenia: An open-label study of olanzapine in adolescents. J. Amer. Child Adolesc. Psychiat., 37:377-385.
38. _ _ _ Zahn, T. P., Wiggs, E., Alaghband-Rad, J., Castellanos, F. X., Frazier, J. A., McKenna, K., Gordon, C. T., Smith, A., Hamburger, S. & Rapoport, J. L. (1998), "Multidimensionally impaired disorder": Is it a variant of very early-onset schizophrenia?. J. Amer. Acad. Child Adolesc. Psychiat., 37:91-99.
39. McClellan, J. & Werry, J. S. (1997), Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J. Amer. Acad. Child Adolesc. Psychiat., 36(10 suppl.):S177-S193.
40. McDougle, C., Holmes, J., Bronson, M., Anderson, G., Volkmar, F., Price, L. & Cohen, D. (1997), Risperdone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study. J. Amer. Acad. Child Adolesc. Psychiat., 36:685-693.
41. _ _ Carlson, D. C., Pelton, G. H., Cohen, D. J. & Price, L. H. (1998), A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch. Gen. Psychiat., 55:633-641.
42. _ Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R. & Price, L. H. (1996), A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorders. Arch. Gen. Psychiat., 53:1001-1008.
43. Naruse, H., Nagahata, M., Nakane, Y., Shirahash, K., Takesada, M. & Yamazaki, K. (1982), A multicenter double-blind trial of pimozide, haloperidol, and placebo in children with behavioral disorders using crossover design. Acta Paedopsychiatrica, 48:173-184.
44. Nicolson, R., Avad, G. & Sloman, L. (1998), An open trial of risperidone in young autistic children. J. Amer. Acad. Child Adolesc. Psychiat., 37:372-376.
45. Pool, D., Bloom, W., Mielke, D. H., Roniger, J. J., Jr. & Gallant, D. M. (1976), A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients. Curr. Ther. Res., 19:99-104.
46. Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J. & Greenhill, L. (1995), Use of methylphenidate in the treatment of children with autistic disorder. J. Autism Dev. Disord., 25:283-294.
47. Ritvo, E. R., Freeman, B. J., Pingree, C., Jorde, L. B., Mason-Brothers, A., Jones, M. B., McMahon, W. M., Petersen, P. B., Jenson, W. R. & Mo, A. (1989), The UCLA-University of Utah Epidemiologic Survey of Autism: Prevalence. Amer. J. Psychiat., 146:1032-1036.
48. Ross, D. L., Klykylo, W. M. & Hitzemann, R. (1987), Reduction of elevated CSF beta-endorphins by fenfluramine in infantile autism. Pediat. Neurol., 3:83-86.
49. Rutter, M. (1978), Diagnosis and definition. In: Autism: A Reappraisal of Concepts and Treatment, ed. M. Rutter & E. Schopler. New York: Plenum, 1:1-25.
50. Siméon, J. G., Carrey, N. J. & Wiggings, D. M. (1995), Risperidone effects in treatment-resistant adolescents: Preliminary case reports. J. Child Adolesc. Psychopharmacol., 5:69-79.
51. Spencer, E. K. & Campbell, M. (1994), Children with schizophrenia: Diagnosis, phenomenology, and pharmachotherapy. Schizophr. Bull., 20:713-725.
52. Stefanatos, G. A., Grover, W. & Geller, E. (1995), Autism and autistic-like conditions in Swedish rural and urban areas: A population study. Br. J. Psychiat., 149:81-87.
53. Steinberg, D. (1985), Psychotic and Other Severe Disturbances in Adolescent Psychiatry: Modern Approaches. Oxford, England: Blackwell Scientific.
54. Steingard, R. & Biederman, J. (1987), Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J. Amer. Acad. Child Adolesc. Psychiat., 26:932-935.
55. _ Zimnitzky, B., Demaso, D. R., Bauman, M. L. & Bucci, J. P. (1997), Sertraline treatment of transition-associated anxiety and agitation in children with autistic disorder. J. Child Adolesc. Psychopharmacol., 7:9-15.
56. Tsai, L. Y. & Ghazinddin, M. (1997), Autistic disorder. In: Textbook of Child & Adolescent Psychiatry, ed. J. M. Wiener. Washington, DC: American Psychiatric Press, 18:255-280.
57. Volkmar, F. R. (1996), Childhood and adolescent psychosis: A review of the past 10 years. J. Amer. Acad. Child Adolesc. Psychiat., 35:843-851.
58. _ Szatmari, P. & Sparrow, S. S. (1993), Sex differences in pervasive developmental disorders. J. Autism Dev. Disord., 23:579-591.
59. Werry, J. S. (1991), Child and adolescent schizophrenia, bipolar, and schizoaffective disorders: A clinical and outcome study. J. Amer. Acad. Child Adolesc. Psychiat., 30:457-465.